Eukles Asset Management’s Organon & Co OGN Stock Holding History

Eukles Asset Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4	Closed	-$58	–	243
2023 Q4	$58	Hold	4	–	–	﹤0.01%	235
2023 Q3	$69	Hold	4	–	–	﹤0.01%	242
2023 Q2	$83	Hold	4	–	–	﹤0.01%	236
2023 Q1	$94	Hold	4	–	–	﹤0.01%	216
2022 Q4	$0	Hold	4	–	–	﹤0.01%	214
2022 Q3	$0	Hold	4	–	–	﹤0.01%	211
2022 Q2	$0	Buy	+4	New	+$140	﹤0.01%	209
2022 Q1	–	Sell	-4	Closed	–	–	213
2021 Q4	$0	Hold	4	–	–	﹤0.01%	222
2021 Q3	$0	Hold	4	–	–	﹤0.01%	230
2021 Q2	$0	Buy	+4	New	+$132	﹤0.01%	238

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Eukles Asset Management's OGN Position: Q1 2024 in Review

Eukles Asset Management sold out of Organon & Co (OGN) in Q1 2024, closing a stake of 4 shares — an estimated $58 sold.

Eukles Asset Management first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $94 in Q1 2023. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2024.

Eukles Asset Management reported no remaining Organon & Co position as of Q1 2024 after selling out during the quarter.
Eukles Asset Management sold 4 Organon & Co shares in Q1 2024, an estimated $58.
Eukles Asset Management first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
Eukles Asset Management's Organon & Co position peaked at $94 in Q1 2023.
720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2024.

Based on Eukles Asset Management's 13F filing for Q1 2024, filed 13 May 2024.